









|
| @ŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‰ïŽ ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ[ƒiƒ‹ |
<< Šw‰ïނ֖߂é
<< ‘O‚̃y[ƒW‚Ö–ß‚é
‘æ101‰ñŠwpW‰ïi•½¬13”N6ŒŽ17“új
yˆê”ʉ‰‘èz
TJ—Ö@‚ª’˜Œø‚µ‚½normal sized ovarian cancer‚Ì1—á
”öè@P’j, –ìŒû@Œ°ˆê, “ˆä@–ž—ç, –]ŒŽ@•üŽq, ‰–ì@Ž ’B, ‚‹´@Nˆê, Šâ‰º@Œõ—˜, ’†‘º@K—Y
ˆÇ—Ñ‘åŠwŽY•wl‰È
“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñ, 38(2)
116-116, 2001
|